ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
10 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
American Society of Hematology Scholar Awards
The ASH Scholar Awards are designed to support hematologists who have chosen a career in research by providing partial salary or other support during that critical period required for completion of training and achievement of status as an independent investigator.
Awards are limited to a maximum of $100,000 for fellow scholars and $150,000 for junior faculty scholars over a two- to three-year period, with an annual maximum of $50,000 for fellows and $75,000 for junior faculty. Up to 15 percent of the award can be (but is not required to be) used for benefits, including medical and dental insurance, life insurance, and retirement benefits.
All awards are activated on July 1 of the following year. The applicant has the option of concluding the award on June 30, two or three years after activation. All award payments are made on a quarterly basis - the amount depends on whether the award is being spread over two or three years. Payments are made to the appropriate financial officer of the institution as indicated on the proposed budget within the full application.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, cells and animals, as well as samples obtained from humans, all of which are designed to further our understanding of the blood, bone marrow, and related organs or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials. The proposal should address clinical applications - not just test development - although the development of novel instrumentation of value to hematology is clearly within the scope of the application. Clinical trial projects with laboratory correlatives are considered clinical.
Clinical Research: ASH considers clinical/translational research to include patient-oriented research and outcomes-based research. ASH emphasizes that clinical research must involve substantial interaction with patients.
For the purposes of the ASH Scholar Awards program, patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
ASH strongly encourages applications in outcomes-based research. Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Applications that fall within any of the categories discussed above are encouraged.
Letter of Intent Due: Wednesday, May 7, 2014
Application Made Available for Those Who Successfully Submit a LOI by the Deadline: Thursday, June 5, 2014
Application Deadline Friday, August 1, 2014
Award Winners Notified: Mid-November, 2014
Activation of Award: Wednesday, July 1, 2015
These eligibility requirements are evaluated as of the date of the LOI submission.
Eligible applicants must be a citizen of the United States or Canada or hold a visa in the United States or Canada.
Eligible applicants must conduct research within the US or Canada
Scholar Award applicants are required to be members of ASH in good standing at the time of the Letter of Intent submission, and for the duration of the Scholar Award Program. If your membership application is pending at the time of the Scholar Award application deadline, you will still be considered for a Scholar Award.
To verify your membership status, please log on to the membership section of the ASH website. If you need assistance with your username and password, please contact an ASH Customer Relations Representative at firstname.lastname@example.org.
Fellow Scholar Awards
PhD or MD/PhD applicants must have fewer than 5 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants should have more than 3 but fewer than 5 years of research experience (including research performed during fellowship, but excluding clinical fellowship time)
MD applicants with fewer than 3 years research experience (inclusive of fellowship research time) should consider applying for the Senior RTAF award
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience
Junior Faculty Scholar Awards
MD, PhD or MD/PhD applicants must have more than 5 but fewer than 10 years of research experience after completion of their PhD (including research performed during fellowship, but excluding clinical fellowship time)
Applicants with the title of Assistant Professor or equivalent *must* apply for the Junior Faculty Award, regardless of research experience.
American Society of Hematology Bridge Grant Program
All applicants must submit proposals to conduct research in hematology.
ASH considers basic research to include a broad spectrum of studies on genes, proteins, lipids, carbohydrates, biochemical and signaling pathways, receptors, hematopoietic cells, and samples obtained from human patients or from vertebrate animal models. For the purpose of this grant, hematology-related basic research is designed to further our understanding of the blood, bone marrow, and related organs and/or the pathogenesis of blood disorders. The emphasis for grants in this category should be on the discovery of new knowledge in a traditional laboratory setting.
ASH defines translational research as using knowledge of human biology to develop and test the feasibility of relevant interventions in humans and/or determine the biological basis for observations made in individuals with hematologic conditions or in populations at risk. Translational research should be founded on and directly connected to some aspect of human biology and may encompass any form of structural, biochemical, genetic, or other appropriate experimental approaches using human materials.
Patient-Oriented Clinical Research
Patient-oriented research is defined as research conducted with human subjects and involves an investigator directly interacting with human subjects. Categories of patient-oriented research include: 1) mechanisms of human disease, 2) therapeutic interventions, 3) clinical trials, and 4) development of new technologies.
Options for outcomes-based research include: 1) a decision-analysis or cost-effectiveness analysis of a relevant topic within hematology, 2) survey-based research investigating practice patterns, access to care, quality of care, clinical outcomes, or quality of life among patients with hematologic conditions, 3) retrospective analyses of large administrative databases (e.g., CMS, a large insurer, SEER) that may enlighten health-care policy decisions related to hematologic disease, and 4) large scale epidemiologic or genetic epidemiologic studies that define the incidence, prevalence, prognosis, and natural history or the effects of therapy of blood disorders.
Application deadline: June 1, 2014
Application notification of acceptance: Mid-Late July, 2014
To be eligible for the ASH Bridge Grant Award all applicants must:
Have submitted a hematology-related R01 or equivalent application to NIH in the past 18 months that was scored but not funded.
ASH uses the NIH definition of R01 equivalence: “R01-equivalent awards include R01, R23, R29, and R37 activity codes and, beginning in fiscal year 2008, DP2 awards to first-time NIH investigators. Not all of these activities are in use by NIH every year.”
The 18 month timeline is linked specifically to the date your R01 was reviewed by the NIH study section.
Be an ASH member or have a pending application for membership at the time of application.
If you have a pending application and are awarded a Bridge Grant Award, your award will be conditional based upon membership approval
Hold a faculty position in an academic institution or the equivalent position in a non-profit research organization. Employees of independent research institutions are eligible to apply if they have a faculty type appointment and the institution is allowed to independently apply for and receive NIH funding.
At the time of award activation, the amount of other research funding available to the principal investigator may not exceed $250,000 annually. This amount does not include the applicant’s salary/fringe and funding from within the institution.
Hematologists eligible to apply for the ASH Scholar Award are not eligible to apply for this award.
Individuals cannot hold an ASH Scholar Award and ASH Bridge Grant concurrently. ASH Scholars can apply if their award terminates before the commencement of the bridge grant.
Applicants can apply a maximum of three times over the three-year award program.
Previous Bridge Grant award recipients cannot apply for a second award.
Call for Applications: American Society of Transplantation Clinical Science Faculty Development Grant
Applications must be submitted by Monday, September 15, 2014. The funding of any grant and total number of grants awarded by the AST is dependent on budgetary constraints in a given year.
2015 Clinical Science Research Priorities
The AST has identified the following research priorities for 2015, and encourages investigators working within these areas to apply for funding by the AST:
Reducing post-transplant complications
Optimizing organ utilization (appropriate allocation and improving organ viability by interventions in the pre-transplant period including ex vivo conditioning)
Preventing late graft failure – cellular and humoral chronic rejection, recurrent and de novo GN
Improving the patient experience and addressing the challenges of therapy adherence
This is a one- or two-year $50,000/year grant for Junior Faculty. The goal of the AST Clinical Science Faculty Development Grant is to promote the careers of young independent investigators within the first five years of their first faculty appointment (see eligibility criteria), by providing funds allowing them to expand on preliminary research findings that will become the basis for individual research or career development awards from the NIH, VA, or equivalent agencies. Clinical Science Grants cover two main categories: Clinical Trials and Clinical Outcomes.
Clinical Trials: should be designed to answer specific question(s) about new therapies or new ways of using known treatments. Preference will be given to prospective studies.
Clinical Outcomes or Observational Studies: should be designed to better define the causes and/or consequences of pathological or biological processes in transplantation. Retrospective studies may be appropriate. However, proposals that analyze registry data (e.g. data collected by the United Network for Organ Sharing) are expected to test unique hypotheses or employ new data or methodologies. The analysis, including the statistics, should be performed by the applicant and not by the providing data registry group.
The AST supports a wide range of basic and clinical research topics. Research topics that involve under-represented areas including minorities, women, and pediatrics are strongly encouraged. The AST also encourages applications from women and minority researchers. Under-represented minority investigators are defined as individuals belonging to a particular ethnic or racial group as determined by the NIH. Established AST members are encouraged to bring this funding opportunity to the attention of new faculty members performing transplantation research at their institutions and to support their applications.
Eligibility Criteria for the AST Clinical Science Faculty Development Grant
Please pay particular attention to the eligibility requirements, as requirements vary for different AST Grants.
Academic Appointment and Institutional Resources: The applicant must have an academic appointment at an accredited institution of higher learning and be within five years of his/her initial academic faculty appointment at the time of the grant application. Regardless of academic title (including instructor, research associate, or equivalent), the AST defines initiation of faculty appointment as the date that the applicant obtained an institutional commitment towards an independent career which includes: a) an office distinct from lab space and/or independent lab space; and b) a start-up package or grant funds controlled by the applicant to work on projects that are independent from his/her mentor. For all applicants, a letter from the Department Chair is required that explicitly addresses: a) the date (month/year) of the first faculty appointment; b) that institutional commitment to the faculty member is sufficient to conduct independent research; c) the amount of protected research time (at least 75%) should this grant be awarded; and d) independence.
Failure to adequately document that the applicant is an independent faculty member with less than five years’ experience will disqualify the application without further review. The applicant must state the date (month and year) of their first faculty appointment in the appropriate space on the contact information page of the application. Note that changing institutions once after having already become a faculty member does not restart the five year time period.
The five year time-frame may be extended if there are extenuating circumstances requiring a leave from relevant academic activities (e.g. child-bearing, armed services commitment). These will be considered on a case-by-case basis and must be accompanied by a letter of explanation by the applicant.
An individual may apply for the AST Faculty Grant while still in training, however, he/she must have been offered and accepted a faculty position that will begin on or before initiation of the grant. In this case, the applicant must submit a letter from the Department Chair of his/her future department that confirms the institutional appointment and provides assurance that the candidate will have an office and/or independent lab space. The letter should also confirm that the candidate will have sufficient start up funds to carry out the project that are independently controlled by the candidate to perform his/her work independently from his/her mentor. Additionally, the letter should stipulate the amount of protected research time (at least 75%) should this grant be awarded.
AST Membership: The applicant must be an active member of the AST or have submitted a completed membership application by September 15, 2014 (with expectation that membership will be active before the grant review occurs). Applicant’s membership dues must be paid to date by November 1, 2014, otherwise, the application will not be considered for funding.
The proposed work is to be performed in a North American laboratory.
Education: The applicant must have an MD, DO, PhD, DVM, or equivalent graduate degree, and have completed post-graduate training (residencies, post-doctoral fellowships, etc.) at the time of the application.
Citizenship: The applicant must be either: a) U.S., Canadian, or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the U.S., Canada, or Mexico with a valid visa during the awarded period; or c) a foreign national admitted lawfully for residence in the U.S., Canada, or Mexico during the awarded period. Funding will not be released until visa status is confirmed.
Previous/Additional Funding: An individual cannot apply for an AST Clinical Science Faculty Development Grant if he/she has been awarded any AST Faculty Grant (or joint grant between AST and another society) in the past. A candidate is also ineligible if they are a PI on a previous or current NIH grant to perform independent research (RO1, project on a PO1 grant,R21, VA Merit award or comparable non-mentored award). However, an applicant may have current or previous Career Development Awards or Grants-in-Aid. A concomitant K Award or comparable mentored award is permitted if the applicant is ready to establish independence of previous mentors and has already become or has been offered and accepted an independent faculty position, as defined above. This should be specifically addressed in the letter from the Department Chair.
The AST Clinical Science Faculty Development Grant project must be distinct from that of any concurrent award. Moreover, this work should not directly overlap with funded projects of other faculty members within the same Section or Department.
Note: Faculty may only hold ONE new AST Grant per year as a PI of a Faculty Development Grant, or as mentor/sponsor of a Fellowship Grant. If more than one grant from a given faculty member (as PI or mentor) is submitted and deemed competitive for funding, the AST will determine which grant to fund.
Call for Applications: American Society of Transplantation Clinical Science Fellowship Grant
The AST Clinical Science Fellowship Grants are intended to support work that addresses important clinical research questions in transplant candidates, recipients and or donors. The project should provide a strong training vehicle for the applicant, in keeping with the overall mission of the AST Fellowship Grants.
2015 Clinical Science Research Priorities
Improving the patient experience and addressing the challenges of therapy adherence
This is a one- or two-year $50,000/year grant designed to provide salary support for fellows at an early stage of their research training (see Section C: Eligibility Criteria).The goals of the AST Fellowship Grants are:
To foster training of new young investigators who have the potential to contribute to our understanding of transplant science/immunobiology and/or treatment of transplant recipients.
To foster research that is of high merit.
To encourage high quality applicants who want to develop a career in academic transplantation.
Clinical Science Grants cover two main categories: Clinical Trials and Clinical Outcomes.
Clinical Outcomes or Observational Studies: should be designed to better define the causes and/or consequences of pathological or biological processes in transplantation. Retrospective studies may be appropriate. However, proposals that analyze registry data (e.g. data collected by the United Network for Organ Sharing) are expected to test unique hypotheses or employ new data or methodologies. The analysis including the statistics, should be performed by the applicant and not by the providing data registry group.
Eligibility Criteria for the AST Clinical Science Fellowship Grant
The applicant must be sponsored by an active member of the AST. If the sponsor is not a member, he/she must submit a completed membership application by September 15, 2014 (with expectation that membership will be active before the grant review occurs). Membership dues must be paid to date by November 1, 2014; otherwise, the application will not be considered for funding.
The work must be performed at a North American site under the direct mentorship of an AST member.
The applicant must have an MD, DO, PhD, DMV or equivalent graduate degree at the time of the application.
AST Fellowship Grants are meant for individuals who have spent two years or less (at the time of the application) performing research in the area of transplantation since obtaining their last post-doctoral degree (MD, PhD, or equivalent degree). Applicants who have worked in other fields or taken leaves of absences are eligible beyond this two-year period, but this must be directly addressed in the sponsor's letter.
The applicant must be either: a) a US, Canadian or Mexican citizen; b) a lawfully admitted permanent resident foreign national of the US, Canada, or Mexico with a valid visa during the training period; or c) a foreign national admitted lawfully for residence in the US, Canada, or Mexico during the training period. Funding will not be released until visa status is confirmed.
Throughout the period of the grant, the applicant must be at a "fellowship training" level, may not hold an independent faculty level position or a salaried senior staff position (or equivalent). The AST defines an independent faculty level position as: a) Assistant Professor or equivalent; or b) Regardless of title, institutional support that includes independent lab space and/or start-up funds to allow independent research. The applicant does not need to have actually started their fellowship at the time of application.
The Fellowship Grant is intended to support or supplement salary during the period of research training. Residual funds can be used for supplies. Funds cannot be used for indirect costs or institutional overhead. Fellows who have other individual fellowships or grants awarded in their name that support their salary, are not eligible.
The sponsor must guarantee 75% protected time adequate for project completion.
Call for Applications: Early Career Investigator Travel Fellowship for Demyelination and Remyelination: From Mechanism to Therapy
Thursday, June 26, 2014 7:45 AM - 5:45 PM The New York Academy of Sciences
Presented by Biogen Idec and the New York Academy of Sciences
Demyelinating diseases and disorders affect millions of people worldwide. While multiple sclerosis is the one of the most widely recognized myelin-associated disorders, changes to the brain’s white matter can be found in a number of genetic, inflammatory, infectious, cerebrovascular, and neurodegenerative conditions and injuries. New breakthroughs in basic science research on the white matter microenvironment and oligodendrocyte precursor cell development have provided novel potential sites of action for therapeutics. Translation of these discoveries into biomarkers to predict clinical outcomes, and into biologics that can modulate myelination utilizing these pathways, may transform the treatment of currently incurable conditions.
This one-day, translational conference will present recent findings in remyelination and repair from disease models and clinical trials, new techniques for imaging myelination changes in the brain and for screening molecular targets, and emerging therapeutics that promote remyelination.
Call for Abstracts
The deadline for poster abstract submission is Monday, May 5, 2014.
Select poster abstracts will be chosen for short oral presentations. For complete abstract submission instructions, please send an email to email@example.com with "Abstract Information" in the subject line. There is no need to type a message; instructions will be forwarded automatically. Please call 212.298.8620 with any questions.
Call for Early Career Investigator Travel Fellowship Applications
The deadline for submission of applications is Monday, May 5, 2014.
Applications are invited from qualified early career investigators and early career investigators from underrepresented minorities. For detailed information on eligibility and application instructions, please send an email to firstname.lastname@example.org with the words "Fellowship Information" in the subject line. There is no need to type a message; instructions will be forwarded automatically. Please call 212.298.8620 with any questions.
Call for Applications: Alex's Lemonade Stand Foundation Bio-Therapeutics Impact Award
Application due date: June 12, 2014 (11:59 PM ET)
All requests must be submitted using ALSF’s online application.
Alex’s Lemonade Stand Foundation evolved from a young cancer patient’s front yard lemonade stand to a national foundation for childhood cancer.
The Bio-Therapeutics Impact Award accelerates the development of clinical trials for promising biologic approaches to treating childhood cancer. These approaches include, but are not limited to, immunotherapy, gene therapy and small molecules. The award, intended for investigators who are initiating clinical trials or undertaking the pre-clinical work necessary to move into the IND (investigational new drug) phase, totals the maximum of $1.5 million awarded over three years.
Call for Applications: National Niemann-Pick Disease Foundation Edward H. Schuchman Research Fellowship
The National Niemann-Pick Disease Foundation (NNPDF) invites applications for research fellowships examining the biology of Acid Sphingomyelinase Deficiency (ASMD; i.e., Types A and B Niemann-Pick Disease), a rare inherited lysosomal storage disease for which there are no effective therapies.
Those eligible to apply for funding are:
• Predoctoral students with a lab selected and an approved thesis
• M.D., Ph.D and D.V.M postdoctoral researchers
• Early career investigators
Preference will be given to research projects that will improve our understanding of the biology and pathogenesis of ASMD. Preference also will be given to research projects developing new therapies for ASMD and for identifying biomarkers to improvide diagnosis and/or to monitor disease progression and efficacy in clinical trials.
The NNPDF Fellowships provide support of $50,000 per annum for two years ($30,000 per annum for three years for predoctoral fellowships) and are renewable based on performance. Applicants must be currently associated with a recognized laboratory.
This fellowship is named for Edward H. Schuchman, Ph.D. a pioneer in ASMD research, and supporter of those affected by Niemann-Pick Disease.
Applications are due May 1st, 2014, and should be submitted by email to the Research Committee Chair. Applicants will be informed of the funding decision by September 1st, 2014, via email. Fellowships awarded will begin October 1st, 2014.
For further information please contact the National Niemann-Pick Disease Foundation's Central Office.
American College of Sports Medicine Paffenbarger-Blair Fund for Epidemiological Research on Physical Activity
Deadline: Jan 16, 2015
Amount: $10,000.00 USD
Number Given: 1
Dr. Ralph S. Paffenbarger, Jr., a co-recipient of the first Olympic Prize in Exercise Science and Sports Medicine, made an extraordinarily generous gift to the American College of Sports Medicine by donating his share of the award to the College's capital campaign with the monies added to the College's epidemiology endowment. The interest on this contribution makes this grant possible. The intent of this award is to encourage researchers early in their career to become involved with physical activity epidemiology. The applications may focus on observational studies of physical activity and health outcomes, or on randomized controlled trials that are clearly focused on physical activity and important public health issues. Applicants are expected to apply within two (2) years of receiving a postgraduate degree or completion of clinical training. The award will be in the amount of $10,000 for a one year period.
The 2015 ACSM Foundation Research Grant Program application will be made available in the fall. There are two parts to the application. Both Part A and Part B must be submitted as one complete PDF application. Applicants for student research grants must have graduate student status during the term of the grant to be considered for funding. Applicants must be current members of ACSM at the time of submitting an application to be funded. Grants are open to all ACSM members, including international members. However, the NASA initiative is open to U.S. residents only.
The deadline for the 2015 grant application was 5:00 PM ET on January 16, 2015.
You may contact the Research Administration and Programs Department regarding this grant at Tel: (317) 637-9200, ext. 143 or email questions to Jane Senior or Michael F. Dell.
Kathryn Barton Hobbs Medical Research Grant
Liam’s Land Organization is bringing lymphatic malformation research to the forefront. LLO will partner with prestigious childrens’ hospitals and reputable institutions to advance research efforts and clinical trials in lymphatic malformation.
LLO will award up to $25,000 in grant(s) money per year for projects with primary interest in LM. The Kathryn Barton Hobbs Medical Research Grant is considered once per year. Principal investigators must hold post-doctoral or beyond, and be affiliated with institutions with 501(c)(3) status or the equivalent for foreign institutions.
Grant application deadline must be postmarked by Friday, June 20, 2014 for consideration at the August 2014 Board of Director’s meeting.
LLO does not directly conduct research projects. LLO funds research and it takes place a various institutions and hospitals around the world.
Request for Proposals: Clinical Studies on Benign Colorectal Disorders
Letter of Intent Deadline: August 1
Application Deadline: October 1
Through the RFP Program, the Research Foundation intends to encourage the conduct of well designed clinical trials leading to a definitive answer to a specific colorectal program. The goal of the Research Foundation’s RFP program is to foster outstanding research in specific areas of colorectal diseases or disorders leading to the improvement and management of common, yet understudied colorectal questions. Pilot studies or phase I, II, or III trials are all appropriate clinical study designs. A peer review mechanism with emphasis on scientific merit will be used to rate proposals.
• The proposed research must be hypothesis-driven and investigator-initiated
• The proposed research must be conducted within the United States or Canada
• ASCRS member must be the Principal Investigator or a Co-Principal Investigator
• The number of RFP grants and the level of funding will be made at the discretion of the Research Foundation Board of Trustees.
• The award may be funded in whole or in part.
• The award need not be given every year.
• Funds are for direct costs only and are intended to establish new studies.